ABOUT US Mission and Objectives Message from the Chairman Message from the Secretary General Who Are We? Board of Directors Our Members Inspection Board Committees Pharmacovigilance Committee Intellectual Property Rights Committee GCP Committee Reimbursement Committee GPP Committee OTC (Non-Prescription Drugs) Committee PR Committee Regulatory Affairs Committee Anti-Counterfeiting Committee Charter Name of the Association Head Office Mission and Activities of the Association Membership Terms of Joining and Terminating Bodies of the Association General Assembly Board of Directors Inspection Board Internal Audit Secretary General Acquisition of Property Revenues and Expenditures of the Assoc. Dissolution of the Association Records of the Association Charter Amendments Absence of Ruling Applicable Language Founders of the Association Code of Promotion Position Documents SECTORIAL DATA Announcements of Moh & Legislation Frequently Asked Questions NEW DRUGS AND R&D What does it mean to be researcher? What is an “Original” drug? Implementations (Original & Generic) Patent Protection Data Exclusivity PRESS ROOM Press Announcement Press Releases News Insider AİFD Activities Reflections in the Press RESEARCHES AND PUBLICATIONS AIFD ACADEMY About AİFD Academy AİFD Academy Final Declaration Scientific Advisory Board AİFD Academy E-Bulletin Membership TR EN     Home Page » PRESS ROOM » News News Turkish Cancer Patients Are Unable To Access New Drugs On Time 25.08.2010 Şükrü Varol Appointed Deputy Secretary General Of The AİFD 15.07.2010 235 New Drug Candidates Currently In Development To Treat Diabetes 13.07.2010 Serious Problem Detected in Drug Tracking System 20.05.2010 Some 2d-Barcode Readers Are Unable To Read 2d-Barcodes On Drug Boxes! 20.05.2010 AİFD warns of "June 1st" 20.05.2010 Aifd Warns: Problems In Distribution Channels Will Arise From Bringing Deadline Forward To Bar Sale Of Non-2d Barcoded Products 14.05.2010 Access of Turkish Cancer Patients to New Medicines Delayed 09.04.2010 New SUT Draft To Impede Access Of Diabetics To New-Generation Medicines In 45 Provinces 10.03.2010 Uncertainties With The Drug Tracking System Put Patients, Sector In A Bind 18.02.2010 Biotechnology Leader Genzyme Joins AIFD 02.02.2010 AİFD PRESS RELEASE 18.01.2010 New pricing decree to shrink pharma industry by 25% 10.12.2009 Pharma compromise reached 03.12.2009 33.4 Million With HIV Still Alive Thanks to Innovative Drugs and Therapies 30.11.2009 Difficulties Expected, Stemming From New Price Decree 20.11.2009 Armed with Innovative Vaccines, World Fights Swine Flu 12.11.2009 On Patient Rights Day, Patient’s Access To Drugs At Stake 26.10.2009 New Pharma Investments At Stake 12.10.2009 New Pricing Decree To Distress Pharma Industry 01.10.2009 Patient Health May Be At Risk 19.09.2009 Effective Struggle Against Cancer Requires New Drugs and Treatments 16.09.2009 AİFD Welcomes IBSA 08.09.2009 Aifd: "Restricting Tobacco Use Will Make Turkey Healthier" 17.07.2009 AİFD: Close Collaboration And Harsh Penalties Key To Combating Counterfeit Drugs 01.07.2009 According To OECD Innovation Is Key To Emerging From The Current Crisis 24.06.2009 Cancer- Related Death Rates Decrease In Developed Countries 18.06.2009 Turkey’s Competitive Power Results To Be Weak In Innovative Drug Researches 09.06.2009 Muhittin Bilgütay is reelected AIFD Chairperson 03.06.2009 Alp Sevindik, AİFD Secretary General and the Chief Operating Officer 13.05.2009 Eczacıbaşı – Baxter Has Become A Member Of Aifd 03.04.2009 Japanese pharmaceutical giant in Turkey - 38th Member of Aifd is Astellas 31.03.2009 Updated version of the “AİFD Code of Good Promotional Practice” has become effective. 03.09.2008 AİFD Convened its Sixth Ordinary General Assembly 27.05.2008 AİFD: “If adequate conditions are provided, brain-drain can be reversed” 15.04.2008 New R&D Law Will Enhance Investments 26.02.2008 FDA’s Former Associate Commissioner for External Relations, Pitts:"SAFE DRUGS SHOULD BE PRESENTED TO PATIENTS MORE EXPEDITIOUSLY" 11.07.2007 This Years’ Final Activity of the Patient School will take place at the School of Medicine of İstanbul University 19.06.2007 Press Announcement Press Releases News Insider AİFD Activities Reflections in the Press MEMBER LOGIN INSIDER AİFD Right strategies will lead Turkey to a bright future SEARCH IN SITE DID YOU KNOW THAT…? IMPORTANT TERMS SITE MAP USEFUL LINKS CONFIDENTIALITY-TERMS OF USE CONTACT Abbott • Actelion • Alcon • Alexion İlaç Ticaret Ltd. Şti. • Amgen • Astellas • AstraZeneca • Bayer Türk Kimya San. Ltd. Şti. • Boehringer İngelheim • Bristol-Myers Squibb • Celgene • Chiesi • Daiichi-Sankyo • Eczacıbaşı-Baxter • Ferring • Fresenius Kabi • Fresenius Medical Care • Genzyme Sağlık Hizmetleri ve Tedavi Ürünleri Tic.Ltd.Şti. • Gilead Sciences İlaç.Tic. Ltd. Şti. • GlaxoSmithKline • IBSA İlaç San. ve Tic. Ltd. Şti. • Intendis • İ.E.Ulagay • Johnson&Johnson • Lilly • Lundbeck • Merck Serono • MSD Türkiye • Nestle • Novartis Sağlık Ürünleri • Novo Nordisk • Nutricia Klinik Beslenme • Pfizer İlaçları Ltd. Şti • Roche Müstahzarları San. A.Ş. • Sanofi-aventis • Servier • U.C.B. Pharma • Wyeth İlaçları Limited Şirketi • AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).     © Association of Research-Based Pharmaceutical Companies Last Update : 03.09.2010